aluates Reports

$ 0.0

Automative

Global Neuroendocrine Tumor Treatment Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-35G898

Global Neuroendocrine Tumor Treatment Market Insights and Forecast to 2028

BUY CHAPTERS

Global Neuroendocrine Tumor Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-35G898

Report

December 2024

Pages:95

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Exelixis Inc

Advanced Accelerator Applications

Dauntless Pharmaceuticals Inc

Hutchinson Medipharma Limited

Ispen

Novartis

Progenics Pharmaceuticals, Inc.

Tarveda Therapeutics

Neuroendocrine Tumor Treatment Market Size

The global Neuroendocrine Tumor Treatment market is projected to grow from US$ 1632.2 million in 2024 to US$ 2302.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.9% during the forecast period.

Neuroendocrine Tumor Treatment Market

Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are malignant. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung and the rest of the body.

Market Analysis and Insights: Global Neuroendocrine Tumor Treatment Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Neuroendocrine Tumor Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Neuroendocrine Tumor Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Neuroendocrine Tumor Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neuroendocrine Tumor Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Neuroendocrine Tumor Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Neuroendocrine Tumor Treatment revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Neuroendocrine Tumor Treatment Market Report

Report Metric	Details
Report Name	Neuroendocrine Tumor Treatment Market
Accounted market size in 2024	US$ 1632.2 million
Forecasted market size in 2030	US$ 2302.3 million
CAGR	5.9
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Everolimus Sunitinib Lu-Dotatate Lanreotide Octreotide
Segment by Application	Hospitals Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Exelixis, Inc., Advanced Accelerator Applications, Dauntless Pharmaceuticals, Inc., Hutchinson Medipharma Limited, Ispen, Novartis AG, Progenics Pharmaceuticals, Inc., Tarveda Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Neuroendocrine Tumor Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuroendocrine Tumor Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neuroendocrine Tumor Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Neuroendocrine Tumor Treatment Market growing?

Ans: The Neuroendocrine Tumor Treatment Market witnessing a CAGR of 5.9 during the forecast period 2025-2030.

What is the Neuroendocrine Tumor Treatment Market size in 2030?

Ans: The Neuroendocrine Tumor Treatment Market size in 2030 will be US$ 2302.3 million.

Who are the main players in the Neuroendocrine Tumor Treatment Market report?

Ans: The main players in the Neuroendocrine Tumor Treatment Market are Exelixis, Inc., Advanced Accelerator Applications, Dauntless Pharmaceuticals, Inc., Hutchinson Medipharma Limited, Ispen, Novartis AG, Progenics Pharmaceuticals, Inc., Tarveda Therapeutics

What are the Application segmentation covered in the Neuroendocrine Tumor Treatment Market report?

Ans: The Applications covered in the Neuroendocrine Tumor Treatment Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the Neuroendocrine Tumor Treatment Market report?

Ans: The Types covered in the Neuroendocrine Tumor Treatment Market report are Everolimus, Sunitinib, Lu-Dotatate, Lanreotide, Octreotide

Recommended Reports

Cancer Therapy Markets

Neuroendocrine Disorders

Cancer Drug Innovations

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Neuroendocrine Tumor Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Everolimus

1.2.3 Sunitinib

1.2.4 Lu-Dotatate

1.2.5 Lanreotide

1.2.6 Octreotide

1.3 Market by Application

1.3.1 Global Neuroendocrine Tumor Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Neuroendocrine Tumor Treatment Market Perspective (2019-2030)

2.2 Global Neuroendocrine Tumor Treatment Growth Trends by Region

2.2.1 Neuroendocrine Tumor Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Neuroendocrine Tumor Treatment Historic Market Size by Region (2019-2024)

2.2.3 Neuroendocrine Tumor Treatment Forecasted Market Size by Region (2025-2030)

2.3 Neuroendocrine Tumor Treatment Market Dynamics

2.3.1 Neuroendocrine Tumor Treatment Industry Trends

2.3.2 Neuroendocrine Tumor Treatment Market Drivers

2.3.3 Neuroendocrine Tumor Treatment Market Challenges

2.3.4 Neuroendocrine Tumor Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Neuroendocrine Tumor Treatment by Players

3.1.1 Global Neuroendocrine Tumor Treatment Revenue by Players (2019-2024)

3.1.2 Global Neuroendocrine Tumor Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Neuroendocrine Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Neuroendocrine Tumor Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Neuroendocrine Tumor Treatment Market Concentration Ratio

3.4.1 Global Neuroendocrine Tumor Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Neuroendocrine Tumor Treatment Revenue in 2023

3.5 Global Key Players of Neuroendocrine Tumor Treatment Head office and Area Served

3.6 Global Key Players of Neuroendocrine Tumor Treatment, Product and Application

3.7 Global Key Players of Neuroendocrine Tumor Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Neuroendocrine Tumor Treatment Breakdown Data by Type

4.1 Global Neuroendocrine Tumor Treatment Historic Market Size by Type (2019-2024)

4.2 Global Neuroendocrine Tumor Treatment Forecasted Market Size by Type (2025-2030)

5 Neuroendocrine Tumor Treatment Breakdown Data by Application

5.1 Global Neuroendocrine Tumor Treatment Historic Market Size by Application (2019-2024)

5.2 Global Neuroendocrine Tumor Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Neuroendocrine Tumor Treatment Market Size (2019-2030)

6.2 North America Neuroendocrine Tumor Treatment Market Size by Type

6.2.1 North America Neuroendocrine Tumor Treatment Market Size by Type (2019-2024)

6.2.2 North America Neuroendocrine Tumor Treatment Market Size by Type (2025-2030)

6.2.3 North America Neuroendocrine Tumor Treatment Market Share by Type (2019-2030)

6.3 North America Neuroendocrine Tumor Treatment Market Size by Application

6.3.1 North America Neuroendocrine Tumor Treatment Market Size by Application (2019-2024)

6.3.2 North America Neuroendocrine Tumor Treatment Market Size by Application (2025-2030)

6.3.3 North America Neuroendocrine Tumor Treatment Market Share by Application (2019-2030)

6.4 North America Neuroendocrine Tumor Treatment Market Size by Country

6.4.1 North America Neuroendocrine Tumor Treatment Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Neuroendocrine Tumor Treatment Market Size by Country (2019-2024)

6.4.3 North America Neuroendocrine Tumor Treatment Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Neuroendocrine Tumor Treatment Market Size (2019-2030)

7.2 Europe Neuroendocrine Tumor Treatment Market Size by Type

7.2.1 Europe Neuroendocrine Tumor Treatment Market Size by Type (2019-2024)

7.2.2 Europe Neuroendocrine Tumor Treatment Market Size by Type (2025-2030)

7.2.3 Europe Neuroendocrine Tumor Treatment Market Share by Type (2019-2030)

7.3 Europe Neuroendocrine Tumor Treatment Market Size by Application

7.3.1 Europe Neuroendocrine Tumor Treatment Market Size by Application (2019-2024)

7.3.2 Europe Neuroendocrine Tumor Treatment Market Size by Application (2025-2030)

7.3.3 Europe Neuroendocrine Tumor Treatment Market Share by Application (2019-2030)

7.4 Europe Neuroendocrine Tumor Treatment Market Size by Country

7.4.1 Europe Neuroendocrine Tumor Treatment Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Neuroendocrine Tumor Treatment Market Size by Country (2019-2024)

7.4.3 Europe Neuroendocrine Tumor Treatment Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Neuroendocrine Tumor Treatment Market Size (2019-2030)

8.2 China Neuroendocrine Tumor Treatment Market Size by Type

8.2.1 China Neuroendocrine Tumor Treatment Market Size by Type (2019-2024)

8.2.2 China Neuroendocrine Tumor Treatment Market Size by Type (2025-2030)

8.2.3 China Neuroendocrine Tumor Treatment Market Share by Type (2019-2030)

8.3 China Neuroendocrine Tumor Treatment Market Size by Application

8.3.1 China Neuroendocrine Tumor Treatment Market Size by Application (2019-2024)

8.3.2 China Neuroendocrine Tumor Treatment Market Size by Application (2025-2030)

8.3.3 China Neuroendocrine Tumor Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Neuroendocrine Tumor Treatment Market Size (2019-2030)

9.2 Asia Neuroendocrine Tumor Treatment Market Size by Type

9.2.1 Asia Neuroendocrine Tumor Treatment Market Size by Type (2019-2024)

9.2.2 Asia Neuroendocrine Tumor Treatment Market Size by Type (2025-2030)

9.2.3 Asia Neuroendocrine Tumor Treatment Market Share by Type (2019-2030)

9.3 Asia Neuroendocrine Tumor Treatment Market Size by Application

9.3.1 Asia Neuroendocrine Tumor Treatment Market Size by Application (2019-2024)

9.3.2 Asia Neuroendocrine Tumor Treatment Market Size by Application (2025-2030)

9.3.3 Asia Neuroendocrine Tumor Treatment Market Share by Application (2019-2030)

9.4 Asia Neuroendocrine Tumor Treatment Market Size by Region

9.4.1 Asia Neuroendocrine Tumor Treatment Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Neuroendocrine Tumor Treatment Market Size by Region (2019-2024)

9.4.3 Asia Neuroendocrine Tumor Treatment Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Type

10.2.1 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Application

10.3.1 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Country

10.4.1 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Exelixis, Inc.

11.1.1 Exelixis, Inc. Company Details

11.1.2 Exelixis, Inc. Business Overview

11.1.3 Exelixis, Inc. Neuroendocrine Tumor Treatment Introduction

11.1.4 Exelixis, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2019-2024)

11.1.5 Exelixis, Inc. Recent Developments

11.2 Advanced Accelerator Applications

11.2.1 Advanced Accelerator Applications Company Details

11.2.2 Advanced Accelerator Applications Business Overview

11.2.3 Advanced Accelerator Applications Neuroendocrine Tumor Treatment Introduction

11.2.4 Advanced Accelerator Applications Revenue in Neuroendocrine Tumor Treatment Business (2019-2024)

11.2.5 Advanced Accelerator Applications Recent Developments

11.3 Dauntless Pharmaceuticals, Inc.

11.3.1 Dauntless Pharmaceuticals, Inc. Company Details

11.3.2 Dauntless Pharmaceuticals, Inc. Business Overview

11.3.3 Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Introduction

11.3.4 Dauntless Pharmaceuticals, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2019-2024)

11.3.5 Dauntless Pharmaceuticals, Inc. Recent Developments

11.4 Hutchinson Medipharma Limited

11.4.1 Hutchinson Medipharma Limited Company Details

11.4.2 Hutchinson Medipharma Limited Business Overview

11.4.3 Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Introduction

11.4.4 Hutchinson Medipharma Limited Revenue in Neuroendocrine Tumor Treatment Business (2019-2024)

11.4.5 Hutchinson Medipharma Limited Recent Developments

11.5 Ispen

11.5.1 Ispen Company Details

11.5.2 Ispen Business Overview

11.5.3 Ispen Neuroendocrine Tumor Treatment Introduction

11.5.4 Ispen Revenue in Neuroendocrine Tumor Treatment Business (2019-2024)

11.5.5 Ispen Recent Developments

11.6 Novartis AG

11.6.1 Novartis AG Company Details

11.6.2 Novartis AG Business Overview

11.6.3 Novartis AG Neuroendocrine Tumor Treatment Introduction

11.6.4 Novartis AG Revenue in Neuroendocrine Tumor Treatment Business (2019-2024)

11.6.5 Novartis AG Recent Developments

11.7 Progenics Pharmaceuticals, Inc.

11.7.1 Progenics Pharmaceuticals, Inc. Company Details

11.7.2 Progenics Pharmaceuticals, Inc. Business Overview

11.7.3 Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Introduction

11.7.4 Progenics Pharmaceuticals, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2019-2024)

11.7.5 Progenics Pharmaceuticals, Inc. Recent Developments

11.8 Tarveda Therapeutics

11.8.1 Tarveda Therapeutics Company Details

11.8.2 Tarveda Therapeutics Business Overview

11.8.3 Tarveda Therapeutics Neuroendocrine Tumor Treatment Introduction

11.8.4 Tarveda Therapeutics Revenue in Neuroendocrine Tumor Treatment Business (2019-2024)

11.8.5 Tarveda Therapeutics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Exelixis Inc

Advanced Accelerator Applications

Dauntless Pharmaceuticals Inc

Hutchinson Medipharma Limited

Ispen

Novartis

Progenics Pharmaceuticals, Inc.

Tarveda Therapeutics

List of Tables

Table 1. Global Neuroendocrine Tumor Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Everolimus

Table 3. Key Players of Sunitinib

Table 4. Key Players of Lu-Dotatate

Table 5. Key Players of Lanreotide

Table 6. Key Players of Octreotide

Table 7. Global Neuroendocrine Tumor Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 8. Global Neuroendocrine Tumor Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Neuroendocrine Tumor Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Neuroendocrine Tumor Treatment Market Share by Region (2019-2024)

Table 11. Global Neuroendocrine Tumor Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Neuroendocrine Tumor Treatment Market Share by Region (2025-2030)

Table 13. Neuroendocrine Tumor Treatment Market Trends

Table 14. Neuroendocrine Tumor Treatment Market Drivers

Table 15. Neuroendocrine Tumor Treatment Market Challenges

Table 16. Neuroendocrine Tumor Treatment Market Restraints

Table 17. Global Neuroendocrine Tumor Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Neuroendocrine Tumor Treatment Revenue Share by Players (2019-2024)

Table 19. Global Top Neuroendocrine Tumor Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroendocrine Tumor Treatment as of 2023)

Table 20. Global Neuroendocrine Tumor Treatment Industry Ranking 2022 VS 2023 VS 2024

Table 21. Global 5 Largest Players Market Share by Neuroendocrine Tumor Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Neuroendocrine Tumor Treatment, Headquarters and Area Served

Table 23. Global Key Players of Neuroendocrine Tumor Treatment, Product and Application

Table 24. Global Key Players of Neuroendocrine Tumor Treatment, Product and Application

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Neuroendocrine Tumor Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Neuroendocrine Tumor Treatment Revenue Market Share by Type (2019-2024)

Table 28. Global Neuroendocrine Tumor Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Neuroendocrine Tumor Treatment Revenue Market Share by Type (2025-2030)

Table 30. Global Neuroendocrine Tumor Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Neuroendocrine Tumor Treatment Revenue Share by Application (2019-2024)

Table 32. Global Neuroendocrine Tumor Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Neuroendocrine Tumor Treatment Revenue Share by Application (2025-2030)

Table 34. North America Neuroendocrine Tumor Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America Neuroendocrine Tumor Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America Neuroendocrine Tumor Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America Neuroendocrine Tumor Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America Neuroendocrine Tumor Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Neuroendocrine Tumor Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Neuroendocrine Tumor Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Neuroendocrine Tumor Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe Neuroendocrine Tumor Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe Neuroendocrine Tumor Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe Neuroendocrine Tumor Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe Neuroendocrine Tumor Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe Neuroendocrine Tumor Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe Neuroendocrine Tumor Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 48. China Neuroendocrine Tumor Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 49. China Neuroendocrine Tumor Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 50. China Neuroendocrine Tumor Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 51. China Neuroendocrine Tumor Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia Neuroendocrine Tumor Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia Neuroendocrine Tumor Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia Neuroendocrine Tumor Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia Neuroendocrine Tumor Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia Neuroendocrine Tumor Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia Neuroendocrine Tumor Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia Neuroendocrine Tumor Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 66. Exelixis, Inc. Company Details

Table 67. Exelixis, Inc. Business Overview

Table 68. Exelixis, Inc. Neuroendocrine Tumor Treatment Product

Table 69. Exelixis, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) & (US$ Million)

Table 70. Exelixis, Inc. Recent Developments

Table 71. Advanced Accelerator Applications Company Details

Table 72. Advanced Accelerator Applications Business Overview

Table 73. Advanced Accelerator Applications Neuroendocrine Tumor Treatment Product

Table 74. Advanced Accelerator Applications Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) & (US$ Million)

Table 75. Advanced Accelerator Applications Recent Developments

Table 76. Dauntless Pharmaceuticals, Inc. Company Details

Table 77. Dauntless Pharmaceuticals, Inc. Business Overview

Table 78. Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Product

Table 79. Dauntless Pharmaceuticals, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) & (US$ Million)

Table 80. Dauntless Pharmaceuticals, Inc. Recent Developments

Table 81. Hutchinson Medipharma Limited Company Details

Table 82. Hutchinson Medipharma Limited Business Overview

Table 83. Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Product

Table 84. Hutchinson Medipharma Limited Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) & (US$ Million)

Table 85. Hutchinson Medipharma Limited Recent Developments

Table 86. Ispen Company Details

Table 87. Ispen Business Overview

Table 88. Ispen Neuroendocrine Tumor Treatment Product

Table 89. Ispen Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) & (US$ Million)

Table 90. Ispen Recent Developments

Table 91. Novartis AG Company Details

Table 92. Novartis AG Business Overview

Table 93. Novartis AG Neuroendocrine Tumor Treatment Product

Table 94. Novartis AG Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) & (US$ Million)

Table 95. Novartis AG Recent Developments

Table 96. Progenics Pharmaceuticals, Inc. Company Details

Table 97. Progenics Pharmaceuticals, Inc. Business Overview

Table 98. Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Product

Table 99. Progenics Pharmaceuticals, Inc. Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) & (US$ Million)

Table 100. Progenics Pharmaceuticals, Inc. Recent Developments

Table 101. Tarveda Therapeutics Company Details

Table 102. Tarveda Therapeutics Business Overview

Table 103. Tarveda Therapeutics Neuroendocrine Tumor Treatment Product

Table 104. Tarveda Therapeutics Revenue in Neuroendocrine Tumor Treatment Business (2019-2024) & (US$ Million)

Table 105. Tarveda Therapeutics Recent Developments

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Neuroendocrine Tumor Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Neuroendocrine Tumor Treatment Market Share by Type: 2023 VS 2030

Figure 3. Everolimus Features

Figure 4. Sunitinib Features

Figure 5. Lu-Dotatate Features

Figure 6. Lanreotide Features

Figure 7. Octreotide Features

Figure 8. Global Neuroendocrine Tumor Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Neuroendocrine Tumor Treatment Market Share by Application: 2023 VS 2030

Figure 10. Hospitals Case Studies

Figure 11. Clinic Case Studies

Figure 12. Others Case Studies

Figure 13. Neuroendocrine Tumor Treatment Report Years Considered

Figure 14. Global Neuroendocrine Tumor Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Neuroendocrine Tumor Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Neuroendocrine Tumor Treatment Market Share by Region: 2023 VS 2030

Figure 17. Global Neuroendocrine Tumor Treatment Market Share by Players in 2023

Figure 18. Global Top Neuroendocrine Tumor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroendocrine Tumor Treatment as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Neuroendocrine Tumor Treatment Revenue in 2023

Figure 20. North America Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Neuroendocrine Tumor Treatment Market Share by Type (2019-2030)

Figure 22. North America Neuroendocrine Tumor Treatment Market Share by Application (2019-2030)

Figure 23. North America Neuroendocrine Tumor Treatment Market Share by Country (2019-2030)

Figure 24. United States Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Neuroendocrine Tumor Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe Neuroendocrine Tumor Treatment Market Share by Type (2019-2030)

Figure 28. Europe Neuroendocrine Tumor Treatment Market Share by Application (2019-2030)

Figure 29. Europe Neuroendocrine Tumor Treatment Market Share by Country (2019-2030)

Figure 30. Germany Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Neuroendocrine Tumor Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China Neuroendocrine Tumor Treatment Market Share by Type (2019-2030)

Figure 38. China Neuroendocrine Tumor Treatment Market Share by Application (2019-2030)

Figure 39. Asia Neuroendocrine Tumor Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia Neuroendocrine Tumor Treatment Market Share by Type (2019-2030)

Figure 41. Asia Neuroendocrine Tumor Treatment Market Share by Application (2019-2030)

Figure 42. Asia Neuroendocrine Tumor Treatment Market Share by Region (2019-2030)

Figure 43. Japan Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America Neuroendocrine Tumor Treatment Market Share by Country (2019-2030)

Figure 53. Brazil Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries Neuroendocrine Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Exelixis, Inc. Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2019-2024)

Figure 60. Advanced Accelerator Applications Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2019-2024)

Figure 61. Dauntless Pharmaceuticals, Inc. Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2019-2024)

Figure 62. Hutchinson Medipharma Limited Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2019-2024)

Figure 63. Ispen Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2019-2024)

Figure 64. Novartis AG Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2019-2024)

Figure 65. Progenics Pharmaceuticals, Inc. Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2019-2024)

Figure 66. Tarveda Therapeutics Revenue Growth Rate in Neuroendocrine Tumor Treatment Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Neuroendocrine Tumor NET Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neuroendocrine Carcinoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neuroendocrine Carcinoma Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gastroenteropancreatic Neuroendocrine Tumor Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neuroendocrine Tumor Drug Market Research Report 2024

Global Primitive Neuroectodermal Tumors PNET Treatment Market Research Report 2024

Global Carcinoid Syndrome Diarrhea Treatment Market Research Report 2024

Global Insulinoma Market Research Report 2024

Global Pancreatic Cancer Diagnostic Market Insights Forecast to 2030

Global Solid Tumor Cancer Treatment Market Insights Forecast to 2030

Global Targeted Therapy for Brain Cancer Market Research Report 2025

Global Cell Separation and Characterization in Solid Tumors Market Insights Forecast to 2030

Global Brain Tumor Therapeutics Market Research Report 2024

Global Neuroendocrine Tumors NETs Treatment Market Insights Forecast to 2030

Global Multiple Endocrine Neoplasia Treatment Market Insights Forecast to 2030

Global Appendiceal Cancer Treatment Market Insights Forecast to 2030

Somatostatin Analogue Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pancreatic Cancer Diagnostic Devices Market Insights Forecast to 2030

Global Neuroblastoma Treatment Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions